Category: Finance
-
Organ Chip Spin-Off Gains $28M in Venture Funds
28 March 2016. A two year-old company developing chip devices that simulate human organs is adding $28 million in venture capital to its treasury. This is the second venture funding round for Emulate Inc., in Boston, a spin-off enterprise from the Wyss Institute for Biologically Inspired Engineering at Harvard University. Emulate Inc. creates plastic chip…
-
Cancer Diagnostics Company Raises $12.3M in IPO
18 March 2016. VolitionRx, a developer of blood tests that screen for cancer and other disorders, is raising some $12.3 million in its initial public stock offering. The Namur, Belgium company, listed on the New York Stock Exchange under the symbol VNRX, issued about 3.8 million shares of common stock priced at $3.25. VolitionRx designs…
-
Breast Cancer Academic Research Program Launched
23 February 2016. Breast Cancer Research Foundation in New York began a new initiative to attract more academic researchers to take part in clinical trials of cancer therapies. The group is starting its Drug Research Collaborative, with a $15 million contribution from drug maker Pfizer, that is also granting research access to its cancer drug…
-
Bayer Funding Studies of Honey Bee Health, Management
18 February 2016. Bayer Crop Science is seeking research ideas for improving the health of honey bee colonies in the U.S. Proposals for studies in the $1 million program addressing urgent needs highlighted by Bayer’s Healthy Hives 2020 initiative are due by 1 March 2016. Bees, which play a key role in agriculture, are facing…
-
Company Hosts Cancer Genome Cloud, Raises $45 Million
16 February 2016. Seven Bridges Genomics, a computational biology company, unveiled its cloud-based cancer genome data sets, in one of three pilot tests for National Cancer Institute. The Cambridge, Massachusetts enterprise also raised $45 million in its first venture funding round. National Cancer Institute, part of National Institutes of Health, aims to make the Cancer…
-
Gene Editing Enlisted to Fight Citrus Greening
11 February 2016. Plant scientists at University of California in Riverside plan to use genome editing to develop varieties of citrus fruit resistant to a bacterial disease devastating crops in the U.S. and other parts of the world. The five-year research project led by UC-Riverside plant pathologist Wenbo Ma is funded by a $4 million…
-
$45M Raised by Protein Folding Drug Discovery Company
10 February 2016. A company discovering new treatments that address errant folding of proteins causing neurological disorders raised $45 million in its first venture funding round. Yumanity Therapeutics, a spin-off enterprise from the Whitehead Institute affiliated with MIT, started in December 2014 and aims to discover therapies for neurodegenerative diseases caused by misfolded proteins. Yumanity…
-
NSF Grant Funds Biosensing Laser Research
9 February 2016. An engineering professor at University of Texas in Arlington received a grant from National Science Foundation for research on lasers with fluid samples to detect indicators of disease. Yuze Sun, known as Alice, is the recipient of a $500,000 Faculty Early Career Development award from NSF, expected to run through 2020. Sun’s…
-
Genome-Editing Company Raises $94 Million in IPO
3 February 2016. Editas Medicine, developer of treatments for disease that harness editing of the human genome, is raising $94.4 million in its initial public stock offering. The company, trading on the Nasdaq exchange under the symbol EDIT, issued 5.9 million shares priced at $16.00. As of 12 noon on 3 February, the stock is…
-
$100K Challenge Seeks Reinvented Clinical Trials
28 January 2016. A challenge at Harvard Business School seeks proposals for better ways of conducting clinical trials that bring to market faster new precision diagnostics and therapies. The competition has a total prize purse of $100,000 and an initial deadline of 13 March 2016. Precision medicine is the term given to emerging practices bringing…